Interaction between COMT Val158Met polymorphism and childhood trauma predicts risk for depression in men
Authors:
- Janaína XavierJXJanaína Xavier
- Clarissa Ribeiro BastosCBClarissa Ribeiro Bastos
- Laísa CameriniLCLaísa Camerini
- Paola Bajadares AmaralPAPaola Bajadares Amaral
- Karen JansenKJKaren Jansen
- Luciano Dias de Mattos SouzaLSLuciano Dias de Mattos Souza
- Ricardo Azevedo da SilvaRSRicardo Azevedo da Silva
- Ricardo Tavares PinheiroRPRicardo Tavares Pinheiro
- Diogo Rizzato LaraDLDiogo Rizzato Lara
- Gabriele GhisleniGGGabriele Ghisleni
- 25 April 2022
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 82 (5) , 385-396
Abstract
Depression is a disabling illness with complex etiology. While the catechol-O-methyltransferase (COMT) gene, in particular the functional Val(158)Met polymorphism, has been related to depression, the mechanisms underlying this gene-disease association are not completely understood. Therefore, we explore the association of COMT Val(158)Met polymorphism with depression as well as its interaction with childhood trauma in 1136 young adults from a population-based study carried out in the city of Pelotas, Brazil. The diagnosis was performed through the Mini International Neuropsychiatric Interview 5.0 (MINI 5.0), and trauma was assessed with the Childhood Trauma Questionnaire (CTQ). Total DNA was extracted and genotyped by real-time PCR, and the QTLbase dataset was queried to perform large-scale quantitative trait locus (QTL) analysis. Our research showed no direct association between the Val(158)Met polymorphism and the diagnosis of depression (women: chi(2) = 0.10, d = 1, p = 0.751; men: chi(2) = 0.003, df = 1, p = 0.956). However, the Met-allele of the Val(158)Met polymorphism modified the effect of childhood trauma in men (OR = 2.58 [95% CI: 1.05-6.29]; p = 0.038) conferring risk for depression only on those who suffer from trauma. The conditional effect from moderation analysis showed that trauma impacts the risk of depression only in men carrying the Met-allele (effect: 0.9490, standard error [SE]: 0.2570; p = 0.0002). QTLbase and dataset for Val(158)Met polymorphism were consistent for markers that influence chromatin accessibility transcription capacity including histone methylation and acetylation. The changes caused in gene regulation by childhood trauma exposure and polymorphism may serve as evidence of the mechanism whereby the interaction increases susceptibility to this disorder in men.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 57 references indexed in Scilit:
- Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findingsJournal of Neurodevelopmental Disorders, 2012
- COMT Val158Met Genotype Determines the Direction of Cognitive Effects Produced by Catechol-O-Methyltransferase InhibitionBiological Psychiatry, 2012
- Genetically determined dopamine availability predicts disposition for depressionBrain and Behavior, 2011
- Impact of interacting functional variants in COMT on regional gray matter volume in human brainNeuroImage, 2009
- Association study of candidate variants of COMT with neuroticism, anxiety and depressionAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Impact of catechol-O-methyltransferase Val108/158 Met genotype on hippocampal and prefrontal gray matter volumeNeuroReport, 2008
- Catechol-O-Methyltransferase (COMT): A Gene Contributing to Sex Differences in Brain Function, and to Sexual Dimorphism in the Predisposition to Psychiatric DisordersNeuropsychopharmacology, 2007
- Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association studyMolecular Psychiatry, 2004
- Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentaisBrazilian Journal of Psychiatry, 2000
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996